COSTEM 2019

The 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies

Berlin, 24-27 October

The 5th meeting of the International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) was held in Berlin, Germany and brought to light a huge array of exciting updates within the transplant field, across numerous disease areas.

Explore the expansive and unique information on controversies important to stem cell transplantation and cellular therapies heard at this meeting.

View all videos

Transplantation

Optimal GVHD prophylaxis in T-cell repleted haploidentical transplantation

Christopher Kanakry

Post-transplant cyclophosphamide mechanisms

Christopher Kanakry

getITD for FLT3-ITD-based MRD monitoring in AML

The “controversial situations” seen in FLT3-mutated AML patients

GvHD

Is endothelial protection effective for GVHD, VOD and TMA?

ASCT in the outpatient setting

MRD

Improving AML outcomes

Charles Craddock

Is MRD monitoring prior to allograft standard in AML?

Multiple Myeloma

The Chinese CAR-T experience

MM: stem cell mobilization regimens with and without plerixafor

Nicolaus Kröger

Lymphoma

CARs: driving the field forward

Can CAR-T cells replace ASCT in DLBCL?

Leukemia

Optimal preparative regimen for AML

Charles Craddock

How will CAR-T cells help us cure Ph+ ALL?

Anemia

Cord vs. haplo in SAA

Aplastic anemia: treatment options in 2019

Antonio Risitano